• Home
  • Articles
  • Expert Sessions
  • Podcasts
  • Weekly Wrap-Ups
  • Cool Tools
  • Events
  • Categories
    • Cell Therapy
    • Downstream Bioprocessing
    • Drug Discovery & Development
    • Gene Therapy
    • Industry Issues
    • News & Announcements
    • Stem Cell Research
    • Upstream Bioprocessing
    • Vaccines
  • Downstream Column
Cell Culture Dish
  • Cell Culture Dish
  • Articles
  • Expert Sessions
  • Podcasts
  • Weekly Wrap-Ups
  • Cool Tools
  • Events
  • Categories
    • Cell Therapy
    • Downstream Bioprocessing
    • Drug Discovery & Development
    • Gene Therapy
    • Industry Issues
    • News & Announcements
    • Stem Cell Research
    • Upstream Bioprocessing
    • Vaccines
  • icon-home
  • Author: J Patrick Moran

J Patrick Moran

Company: The Cell Culture Dish

Job Title: CTO

Linkedin Profile

Intelligent Lentivirus Analysis – Coupling an Automated Imaging System with Artificial Intelligence

The number of gene and cell therapies in the clinic is increasing rapidly. With the increase in gene therapy manufacturing, comes the need for improved analytics during the production process. Analytics for Lentivirus production is ... Continued

December 04, 2019 • Written by J Patrick Moran

Using 3D cell-based human liver microtissue models in predicting adverse effects caused by chronic exposure to engineered nanomaterial

Using 3D cell-based human liver microtissue models to predict adverse effects caused by chronic exposure...

Using Organoids for Disease Modeling

Improving expression and purification of mAb using FectoCHO® Expression System and MabXpure™

Susana Alcantara

Live Cell Analysis for Neuroscience Research

Laboratory based therapeutic and diagnostic marker protein concentration through centrifugal and crossflow ultrafiltration

FectoPRO Packaging

Improved Protein yields in CHO and HEK293 cells using a dedicated transfection reagent: FectoPRO®

New Flexible Bispecific Antibody Format Demonstrates Improved Therapeutic Properties and Manufacturability

Using transposases to generate clones with high, predictable expression and stability

Qualifying a rapid qPCR mycoplasma test approved for CAR-T clinical studies

Biotech 2019

Biopharmaceutical Manufacturing and Single-Use Technologies 2019 Meeting in Review

Show More

Our Sponsor

Categories

  • Cell Culture
  • Cell Therapy
  • Downstream Bioprocessing
  • Drug Discovery & Development
  • Gene Therapy
  • General
  • Industry Issues
  • News & Announcements
  • Stem Cell Research
  • Upstream Bioprocessing
  • Vaccines

Our Sponsor

  • Sponsors & Partners
  • Experts & Contributors
  • Sitemap
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • About The Dish
  • Facebook
  • Twitter
  • linkedin
  • Youtube

Copyright © 2019 The Cell Culture Dish. All Rights Reserved.